Experts believe that GALAPAGOS and GILEAD have managed to make a breakthrough on an experimental autotoxin inhibitor in the field of scleroderma therapy.

Clinical studies on VIR-2218 have shown an effective result in the fight against hepatitis B.

The FDA has assigned an orphan drug status to a drug based on rhenium nanoliposom.

A new class of drugs such as HIF-2α inhibitors is considered as an addition to standard cancer immunotherapy.

Chinese scientists are actively engaged in the development of improved immunomodulators.

Studies have shown that, on average, people eat about 5 grams of plastic every week.

A new control dyslipidemia method has been proposed instead of appropriate statins and lipid-lowering drugs.

Chinese scientists have developed a unique vaccine that is safe and has low adverse reactions.

Scientists have found a way to "recharge" and increase the brain’s performance.

At the moment there is no cure for this disease, but scientists have found out how the disease progresses and how to deal with it in the future.